CD8A and cancer: Previous studies have indicated that cancer cells evade immune surveillance mainly through suppressing the expression of major histocompatibility class I (MHC-I), which, in turn, hinders both the antitumor effect of type II IFN response and the infiltration of CD8+ T cell [34].